John Charles Thomas
General Counsel at Krystal Biotech, Inc. (KRYS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $541K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 26SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,000 | $347.27 | $347K | -8.8% |
| May 27SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 642 | $302.03 | $194K | +4.8% |
- Sell
General Counsel John Charles Thomas sold $347K of KRYS at $347.27 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel John Charles Thomas sold $194K of KRYS at $302.03 — pre-scheduled 10b5-1 plan sale.